Literature DB >> 31433

Potentiation of neostigmine and pyridostigmine by 4-aminopyridine in the rat.

R D Miller, P A Dennissen, F van der Pol, S Agoston, L H Booij, J F Crul.   

Abstract

The interaction between 4-aminopyridine and neostigmine or pyridostigmine was studied in vivo in the rat sciatic nerve-anterior tibialis preparation using the constant infusion of pancuronium technique. The ED50 (dose of drug which produced a 50% antagonism) of neostigmine, pyridostigmine and 4-aminopyridine were 18, 49 and 440 microgram kg(-1) respectively. The addition of 100 microgram kg(-1) of 4-aminopyridine, which produced no antagonism by itself, decreased the neostigmine ED50 to 7.4 microgram kg(-1). The addition of 200 microgram kg(-1) of 4-aminopyridine, which produced a 30% antagonism by itself, decreased the ED50 of pyridostigmine to 11 microgram kg(-1). We conclude that both neostigmine and pyridostigmine interact with 4-aminopyrine synergistically.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 31433     DOI: 10.1111/j.2042-7158.1978.tb13368.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

Review 1.  Recent developments with muscles relaxants and their antagonists.

Authors:  R D Miller
Journal:  Can Anaesth Soc J       Date:  1979-03

Review 2.  Neuromuscular transmission and its pharmacological blockade. Part 3: Continuous infusion of relaxants and reversal and monitoring of relaxation.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

3.  Antagonism of d-tubocurarine-induced neuromuscular blockade with a mixture of 4-aminopyridine and neostigmine in man.

Authors:  K Wirtavuori; M Salmenperä; T Tammisto
Journal:  Can Anaesth Soc J       Date:  1984-11

4.  Antagonistic activity of galanthamine on constant infusion of pancuronium in rats.

Authors:  D A Cozanitis; F van de Pol; H van Wezel; J F Crul
Journal:  Experientia       Date:  1981-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.